Categories: Automobile

JUNGHWAN LEE TRIUMPHS AT 2025 GENESIS CHAMPIONSHIP

  • Junghwan Lee clinched a win with a score of 11-under 273, taking home $680,000 and a Genesis GV80 
  • Marks first-ever victory by a KPGA TOUR player in an event co-sanctioned with an overseas tour 
  • Seungbin Choi, who achieved the best finish among KPGA TOUR players this year, secures a spot in the 2026 Genesis Scottish Open

Frankfurt, Germany, 27 October 2025:  After four days of world-class golf at the Woo Jeong Hills Country Club in Cheonan, Korea, Junghwan Lee claimed victory at the 2025 Genesis Championship (23-26 October), earning him a $680,000 cash prize, a Genesis GV80, and a two-year seed for the DP World Tour and KPGA TOUR, respectively.

- Advertisement -

Lee finished with a total of 11-under-par 273, three strokes ahead of Nacho Elvira from Spain and Laurie Canter from England, who tied for second place. This makes him the first KPGA TOUR player to win a tournament co-sanctioned with an overseas tour.

- Advertisement -

“I’m proud to be the first KPGA TOUR player to win a co-sanctioned event between the KPGA TOUR and an overseas tour,” said Lee. “I think I’ll be giving the GV80 to my wife,” he added, celebrating his victory.

- Advertisement -

Milestone Achievements for Korean Golfers on the Global Stage

- Advertisement -

Lee competed in the Genesis Scottish Open in both 2024 and 2025, having earned exemption rights as one of the top-ranking players on the Genesis Points system. In 2024, he became the first KPGA TOUR player to make the cut at the Scottish Open, finishing tied for 46th.

- Advertisement -

Following Seungtaek Lee, who advanced to the PGA TOUR through the Korn Ferry Tour via the Genesis Points system, Junghwan Lee’s victory at this year’s Genesis Championship has now earned him a place on the DP World Tour — marking another milestone achievement made possible through Genesis’ continued support of golf and Korean men’s professional players’ advancement onto global tours.

- Advertisement -

Meanwhile, Seungbin Choi, who finished tied for 7th (the highest finish among KPGA TOUR players excluding the winner), has earned qualification to compete in the 2026 Genesis Scottish Open.

- Advertisement -

Despite being held outside the Seoul metropolitan area, this year’s tournament drew strong crowds, matching last year’s ticket sales in Songdo, Incheon.

- Advertisement -

Unparalleled On-Site Experiences

- Advertisement -

Along with four Genesis cars displayed throughout the course, including GV80 and G80 Black saloon, spectators enjoyed the Fan Village, where they were able to enjoy a variety of brand experiences. In addition to local delicacies offered at the food court, the Genesis Collection brand merchandise was available for purchase. Spectators also had a chance to try out their swings at the TGL golf simulator.

- Advertisement -

In line with Genesis’ philosophy of providing thoughtful care to both players and caddies, Genesis continued the tradition of the Players and Caddies Café, where players and caddies were able to rest and recharge with an array of signature Korean snacks.

- Advertisement -

Following the Championship, Genesis will return to the green next month at the 2025 Abu Dhabi HSBC Championship as the official car sponsor.

- Advertisement -
TheNews Market

Recent Posts

Hexaware Expands Presence in Gujarat with New Delivery Center at GIFT City

MUMBAI, India, LONDON and ISELIN, N.J., June 13, 2026 /PRNewswire/ -- Hexaware Technologies [NSE: HEXT], a…

30 minutes ago

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026

 -- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI…

1 hour ago

Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

June 13, 2026 07:30 ET  | Source: Intellia Therapeutics, Inc. Data from HAELO Phase 3…

1 hour ago

New TALVEY(talquetamab) plus daratumumab data demonstrate the potential strength of a novel bispecific combination in earlier-line relapsed or refractory multiple myeloma

TALVEY® plus daratumumab with or without pomalidomide showed progression-free survival of up to 81.3% and overall survival of…

1 hour ago

President Droupadi Murmu Confers Kirti Chakra on Chandigarh University Alumnus Major Arshdeep Singh Gill

"Chandigarh University not only provides quality education but also instills a spirit of patriotism," says…

3 hours ago

Bitmine Immersion Technologies Announces Initial Dividends and NYSE Listing for Series A Preferred Stock

Bitmine's Board of Directors declares initial cash dividends on the Company's 9.50% Series A Perpetual…

5 hours ago